Hair Loss News

Navigation

Hair Loss News Archives


October 2013

New Study Will Examine Sexual Dysfunction among Finasteride

A new clinical study funding was announced on August 21, by the Post-Finasteride Syndrome (PFS) Foundation, in order to determine why PFS (including Propecia) patients develop sexual dysfunction.


AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Propecia Lawsuit.

A new clinical study funding was announced on August 21, by the Post-Finasteride Syndrome (PFS) Foundation at the Baylor College of Medicine, in order to determine why PFS patients develop sexual dysfunction.

As the PFS Foundation clearly states “PFS has been reported to occur in men who have taken the prescription drug finasteride to treat hair loss under the brand name Propecia and generics, or enlarged prostates (Proscar and generics).”

Propeciais a pill, manufactured by Merck, for use in males only and indicated for the treatment of male pattern hair loss. It was approved by the FDA in 1997.

Court data updated on September 11, indicate that there are 739 actions pending in the Propecia Multidistrict Litigation (U.S. District Court, Eastern District of New York, MDL 2331 - IN RE: Propecia-Finasteride Products Liability Litigation).

Plaintiffs claim that Merck failed to warn on Propecia side effects that could cause permanent and devastating sexual dysfunction.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Propecia severe complications.

Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Propecia lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On May 23, 2013 safety labeling changes concerning Propecia adverse events were approved by the FDA and included:

Sexual dysfunction that continued after discontinuation of treatment, including erectile dysfunction, libido disorders, ejaculation disorders, and orgasm disorders, male infertility and/or poor seminal quality.

AttorneyOne.com has further information on Propecia lawsuits including how to get in contact with legal counsel.

Source